Search research articles
Contact Us
Filters
Showing results (71-80 of 132) with videos related to
Page
of 14
Sort By:
Blood
|
October 24, 2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission
Franco Locatelli, Myriam Labopin, Juan Ortega, et al.
British Journal of Clinical Pharmacology
|
September 16, 2010
Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation
Lihua Zeng, Elaine Y L Blair, Christa E Nath, et al.
Vaccine
|
August 13, 2019
Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children
C Raina MacIntyre, Peter J Shaw, Fiona E Mackie, et al.
Blood
|
June 17, 2009
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313
Michael A Pulsipher, Kenneth M Boucher, Donna Wall, et al.
British Journal of Clinical Pharmacology
|
February 17, 2016
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation
Christa E Nath, Judith Trotman, Campbell Tiley, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 28, 2021
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
Khalil Ben Hassine, Tiago Nava, Yves Théoret, et al.
British Journal of Clinical Pharmacology
|
June 25, 2010
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
Christa E Nath, Peter J Shaw, Judith Trotman, et al.
Journal of Pediatric Hematology/Oncology
|
December 4, 2020
Hematopoietic Stem Cell Transplantation for Hepatitis-associated Aplastic Anemia Following Liver Transplantation for Nonviral Hepatitis: A Retrospective Analysis and a Review of the Literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation
Alexander B Mohseny, Dirk-Jan A Eikema, Benedicte Neven, et al.
Clinical Pharmacokinetics
|
March 30, 2012
Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing
Imke H Bartelink, Jaap J Boelens, Robbert G M Bredius, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma
Maher K Gandhi, Eleanore Lambley, Jacqueline Burrows, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 132) with videos related to
Sort By:
Page
of 14
Blood
|
October 24, 2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission
Franco Locatelli, Myriam Labopin, Juan Ortega, et al.
British Journal of Clinical Pharmacology
|
September 16, 2010
Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation
Lihua Zeng, Elaine Y L Blair, Christa E Nath, et al.
Vaccine
|
August 13, 2019
Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children
C Raina MacIntyre, Peter J Shaw, Fiona E Mackie, et al.
Blood
|
June 17, 2009
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313
Michael A Pulsipher, Kenneth M Boucher, Donna Wall, et al.
British Journal of Clinical Pharmacology
|
February 17, 2016
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation
Christa E Nath, Judith Trotman, Campbell Tiley, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 28, 2021
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
Khalil Ben Hassine, Tiago Nava, Yves Théoret, et al.
British Journal of Clinical Pharmacology
|
June 25, 2010
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
Christa E Nath, Peter J Shaw, Judith Trotman, et al.
Journal of Pediatric Hematology/Oncology
|
December 4, 2020
Hematopoietic Stem Cell Transplantation for Hepatitis-associated Aplastic Anemia Following Liver Transplantation for Nonviral Hepatitis: A Retrospective Analysis and a Review of the Literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation
Alexander B Mohseny, Dirk-Jan A Eikema, Benedicte Neven, et al.
Clinical Pharmacokinetics
|
March 30, 2012
Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing
Imke H Bartelink, Jaap J Boelens, Robbert G M Bredius, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma
Maher K Gandhi, Eleanore Lambley, Jacqueline Burrows, et al.
Page
of 14